INS and metabolic dysfunction-associated steatotic liver disease: With the globalrise in obesity and metabolic syndrome, NAFLD has emerged as the most common chronic liver disease, affecting approximately 25% of theglobal population and up to 80% of obese individuals [1, 2].The complex interplay between metabolic dysfunction, insulin resistance, inflammation and genetic predisposition underlies thepathophysiology of NAFLD.